- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Aplastic anaemia (AA)
- Meeting Date: November 2023
- Public Summary Document (PSD) November 2023 PBAC Meeting - (PDF 850KB)
- Public Summary Document (PSD) November 2023 PBAC Meeting - (Word 430KB)
Eltrombopag – November 2023
Eltrombopag: Tablet 25 mg, Tablet 50 mg; Revolade®
Last updated
1 March 2024